S. Barry Ticho's most recent trade in Stoke Therapeutics Inc was a trade of 6,728 Common Stock done at an average price of $32.6 . Disclosure was reported to the exchange on July 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 32.62 per share. | 01 Jul 2026 | 6,728 | 28,098 (0%) | 0% | 32.6 | 219,434 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 33.27 per share. | 01 Jul 2026 | 500 | 27,598 (0%) | 0% | 33.3 | 16,634 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 30.58 per share. | 01 Jun 2026 | 1,795 | 34,826 (0%) | 0% | 30.6 | 54,891 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 32.79 per share. | 01 May 2026 | 2,243 | 36,621 (0%) | 0% | 32.8 | 73,548 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 32.66 per share. | 01 Apr 2026 | 1,838 | 38,864 (0%) | 0% | 32.7 | 60,029 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 31.28 per share. | 17 Mar 2026 | 6,100 | 41,384 (0%) | 0% | 31.3 | 190,831 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 32.74 per share. | 17 Mar 2026 | 3,577 | 50,071 (0%) | 0% | 32.7 | 117,109 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 33.38 per share. | 17 Mar 2026 | 2,587 | 47,484 (0%) | 0% | 33.4 | 86,342 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 29.99 per share. | 17 Mar 2026 | 1,461 | 40,702 (0%) | 0% | 30.0 | 43,815 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.19 per share. | 17 Mar 2026 | 1,365 | 42,163 (0%) | 0% | 2.2 | 2,989 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Mar 2026 | 1,365 | 83,035 | - | - | Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 31.79 per share. | 17 Mar 2026 | 483 | 40,901 (0%) | 0% | 31.8 | 15,354 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 32.85 per share. | 17 Mar 2026 | 103 | 40,798 (0%) | 0% | 32.9 | 3,384 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2026 | 13,100 | 13,100 | - | - | Restricted Stock Units | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2026 | 13,100 | 32,898 (0%) | 0% | 0 | Common Stock | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2026 | 10,750 | 32,250 | - | - | Restricted Stock Units | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2026 | 10,750 | 53,648 (0%) | 0% | 0 | Common Stock | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2026 | 10,000 | 20,000 | - | - | Restricted Stock Units | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2026 | 10,000 | 42,898 (0%) | 0% | 0 | Common Stock | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2025 | 10,000 | 0 | - | - | Performance Stock Units | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2025 | 10,000 | 25,156 (0%) | 0% | 0 | Common Stock | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 31.35 per share. | 03 Dec 2025 | 1,989 | 19,798 (0%) | 0% | 31.3 | 62,346 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 31.33 per share. | 03 Dec 2025 | 1,673 | 21,787 (0%) | 0% | 31.3 | 52,416 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 30.76 per share. | 03 Dec 2025 | 1,373 | 23,783 (0%) | 0% | 30.8 | 42,238 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 31.32 per share. | 03 Dec 2025 | 323 | 23,460 (0%) | 0% | 31.3 | 10,115 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2025 | 11,981 | 19,176 (0%) | 0% | 0 | Common Stock | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2025 | 11,981 | 0 | - | - | Restricted Stock Units | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 29.56 per share. | 01 Dec 2025 | 1,244 | 17,932 (0%) | 0% | 29.6 | 36,775 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 30.85 per share. | 01 Dec 2025 | 1,225 | 15,156 (0%) | 0% | 30.8 | 37,788 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 30.34 per share. | 01 Dec 2025 | 789 | 16,381 (0%) | 0% | 30.3 | 23,937 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 30.14 per share. | 01 Dec 2025 | 762 | 17,170 (0%) | 0% | 30.1 | 22,968 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 25.22 per share. | 03 Nov 2025 | 3,776 | 9,350 (0%) | 0% | 25.2 | 95,247 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 26.02 per share. | 03 Nov 2025 | 1,455 | 7,895 (0%) | 0% | 26.0 | 37,860 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 27.54 per share. | 03 Nov 2025 | 600 | 7,295 (0%) | 0% | 27.5 | 16,524 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 29.35 per share. | 03 Nov 2025 | 100 | 7,195 (0%) | 0% | 29.4 | 2,935 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 23.64 per share. | 01 Oct 2025 | 5,343 | 13,126 (0%) | 0% | 23.6 | 126,316 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 19.87 per share. | 02 Sep 2025 | 5,501 | 18,469 (0%) | 0% | 19.9 | 109,325 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 18.24 per share. | 18 Aug 2025 | 2,805 | 23,970 (0%) | 0% | 18.2 | 51,158 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2025 | 20,000 | 20,000 | - | - | Performance Stock Units | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Aug 2025 | 10,000 | 26,775 (0%) | 0% | 0 | Common Stock | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Aug 2025 | 10,000 | 10,000 | - | - | Performance Stock Units | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 12.82 per share. | 01 Aug 2025 | 4,504 | 16,775 (0%) | 0% | 12.8 | 57,724 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 11.63 per share. | 01 Jul 2025 | 4,503 | 21,279 (0%) | 0% | 11.6 | 52,379 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 10.03 per share. | 02 Jun 2025 | 6,471 | 25,782 (0%) | 0% | 10.0 | 64,892 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 02 Jun 2025 | 1,745 | 32,253 (0%) | 0% | 10 | 17,450 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 10.03 per share. | 01 May 2025 | 22,790 | 33,998 (0%) | 0% | 10.0 | 228,543 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 01 May 2025 | 3,841 | 56,788 (0%) | 0% | 10 | 38,410 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2025 | 64,000 | 64,000 | - | - | Employee Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2025 | 43,000 | 43,000 | - | - | Restricted Stock Units | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 8.67 per share. | 18 Mar 2025 | 3,884 | 63,962 (0%) | 0% | 8.7 | 33,674 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 8.27 per share. | 18 Mar 2025 | 3,333 | 60,629 (0%) | 0% | 8.3 | 27,564 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 13,100 | 57,846 (0%) | 0% | 0 | Common Stock | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 13,100 | 26,200 | - | - | Restricted Stock Units | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 10,000 | 67,846 (0%) | 0% | 0 | Common Stock | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 10,000 | 30,000 | - | - | Restricted Stock Units | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 12.99 per share. | 09 Dec 2024 | 2,586 | 44,746 (0%) | 0% | 13.0 | 33,596 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 12.78 per share. | 06 Dec 2024 | 13,945 | 47,332 (0%) | 0% | 12.8 | 178,182 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Dec 2024 | 20,000 | 20,000 | - | - | Performance Stock Units | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2024 | 10,000 | 10,000 | - | - | Performance Stock Units | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2024 | 10,000 | 61,277 (0%) | 0% | 0 | Common Stock | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2024 | 48,792 | 11,981 | - | - | Restricted Stock Unit (RSU) | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2024 | 48,792 | 51,277 (0%) | 0% | 0 | Common Stock | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 12.07 per share. | 01 Dec 2024 | 10,000 | 51,277 (0%) | 0% | 12.1 | 120,698 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 01 Dec 2024 | 10,000 | 61,277 (0%) | 0% | 0.6 | 6,000 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2024 | 10,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2024 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 12.68 per share. | 01 Nov 2024 | 10,000 | 2,485 (0%) | 0% | 12.7 | 126,803 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 01 Nov 2024 | 10,000 | 12,485 (0%) | 0% | 0.6 | 6,000 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 01 Oct 2024 | 10,000 | 12,485 (0%) | 0% | 0.6 | 6,000 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2024 | 10,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 12.06 per share. | 01 Oct 2024 | 10,000 | 2,485 (0%) | 0% | 12.1 | 120,648 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2024 | 10,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 03 Sep 2024 | 10,000 | 12,485 (0%) | 0% | 0.6 | 6,000 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 14.92 per share. | 03 Sep 2024 | 9,400 | 3,085 (0%) | 0% | 14.9 | 140,236 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 15.41 per share. | 03 Sep 2024 | 600 | 2,485 (0%) | 0% | 15.4 | 9,245 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2024 | 10,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 14.58 per share. | 01 Aug 2024 | 10,000 | 2,485 (0%) | 0% | 14.6 | 145,843 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 01 Aug 2024 | 10,000 | 12,485 (0%) | 0% | 0.6 | 6,000 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 13.75 per share. | 01 Jul 2024 | 10,000 | 2,485 (0%) | 0% | 13.7 | 137,458 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 01 Jul 2024 | 10,000 | 12,485 (0%) | 0% | 0.6 | 6,000 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2024 | 10,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 03 Jun 2024 | 10,000 | 12,485 (0%) | 0% | 0.6 | 6,000 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 10,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 15.21 per share. | 03 Jun 2024 | 9,897 | 2,588 (0%) | 0% | 15.2 | 150,560 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 15.78 per share. | 03 Jun 2024 | 103 | 2,485 (0%) | 0% | 15.8 | 1,625 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 01 May 2024 | 10,000 | 12,485 (0%) | 0% | 0.6 | 6,000 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 10,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 11.37 per share. | 01 May 2024 | 10,000 | 2,485 (0%) | 0% | 11.4 | 113,653 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 13.23 per share. | 01 Apr 2024 | 9,426 | 2,485 (0%) | 0% | 13.2 | 124,684 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 01 Apr 2024 | 442 | 11,911 (0%) | 0% | 0.6 | 265 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 442 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2024 | 60,000 | 60,000 | - | - | Employee Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2024 | 40,000 | 40,000 | - | - | Restricted Stock Units | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 13,100 | 39,300 | - | - | Restricted Stock Units | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 13,100 | 15,585 (0%) | 0% | 0 | Common Stock | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 6.10 per share. | 15 Mar 2024 | 4,116 | 11,469 (0%) | 0% | 6.1 | 25,102 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 7.75 per share. | 01 Mar 2024 | 10,000 | 2,485 (0%) | 0% | 7.7 | 77,469 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 01 Mar 2024 | 5,504 | 12,485 (0%) | 0% | 0.6 | 3,302 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 5,504 | 80,442 | - | - | Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | S. Ticho Barry | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 4.80 per share. | 01 Feb 2024 | 10,000 | 6,981 (0%) | 0% | 4.8 | 47,991 | Common Stock |
| Stoke Therapeutics Inc | S. Barry Ticho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 5.74 per share. | 02 Jan 2024 | 10,000 | 16,981 (0%) | 0% | 5.7 | 57,352 | Common Stock |